{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:51:08Z","timestamp":1776156668057,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10238-021-00743-7","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T12:09:24Z","timestamp":1626091764000},"page":"311-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Calprotectin in viral systemic infections\u2014COVID-19 versus hepatitis C virus"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7001-8845","authenticated-orcid":false,"given":"Letitia","family":"Toma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Dodot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Zgura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolae","family":"Bacalbasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Silaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razvan","family":"Simu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Isac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Mercan-Stanciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"743_CR1","first-page":"187","volume-title":"Stimulus response coupling: the role of intracellular calcium-binding proteins","author":"MK Fagherol","year":"1990","unstructured":"Fagherol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leucocyte protein). In: Smith VL, Dedman JR, editors. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton: CRC Press; 1990. p. 187\u2013210."},{"issue":"3","key":"743_CR2","first-page":"183","volume":"12","author":"T Azramezani Kopi","year":"2019","unstructured":"Azramezani Kopi T, Shahrokh S, Mirzaei S, Asadzadeh Aghdaei H, Amini Kadijani A. The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study. Gastroenterol Hepatol Bed Bench. 2019;12(3):183\u20139.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"743_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/jcm9040927","volume":"9","author":"W Hauzer","year":"2020","unstructured":"Hauzer W, Witkiewicz W, Gnus J. Calprotectin and receptor for advanced glycation end products as a potential biomarker in abdominal aortic aneurysm. J Clin Med. 2020;9(4):927. https:\/\/doi.org\/10.3390\/jcm9040927.","journal-title":"J Clin Med"},{"key":"743_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12876-020-1183-x","volume":"20","author":"FGC e Penna","year":"2020","unstructured":"e Penna FGC, Rosa RM, da Cunha PFS, et al. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn\u2019s disease. BMC Gastroenterol. 2020;20:35. https:\/\/doi.org\/10.1186\/s12876-020-1183-x.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"743_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018;113(4):481\u2013517. https:\/\/doi.org\/10.1038\/ajg.2018.27.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"743_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384\u2013413. https:\/\/doi.org\/10.14309\/ajg.0000000000000152.","journal-title":"Am J Gastroenterol"},{"key":"743_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3892\/mmr.2014.2180","volume":"10","author":"M Chang","year":"2014","unstructured":"Chang M, Chou J, Chen S, et al. Fecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Mol Med Rep. 2014;10:522\u20136.","journal-title":"Mol Med Rep"},{"issue":"4","key":"743_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/00365521.2011.648953","volume":"47","author":"E Klingberg","year":"2012","unstructured":"Klingberg E, Carlsten H, Hilme E, Hedberg M, Forsblad-d\u2019Elia H. Calprotectin in ankylosing spondylitis\u2014frequently elevated in feces, but normal in serum. Scand J Gastroenterol. 2012;47(4):435\u201344. https:\/\/doi.org\/10.3109\/00365521.2011.648953.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"743_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jcf.2010.01.005","volume":"9","author":"RD Gray","year":"2010","unstructured":"Gray RD, Imrie M, Boyd AC, Porteous D, Innes JA, Greening AP. Sputum and serum calprotectin are useful biomarkers during CF exacerbation. J Cyst Fibros. 2010;9(3):193\u20138. https:\/\/doi.org\/10.1016\/j.jcf.2010.01.005.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"743_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10067-015-3108-6","volume":"35","author":"Q Guo","year":"2016","unstructured":"Guo Q, Zha X, Li C, et al. Serum calprotectin\u2014a promising diagnostic marker for adult-onset Still\u2019s disease. Clin Rheumatol. 2016;35(1):73\u20139. https:\/\/doi.org\/10.1007\/s10067-015-3108-6.","journal-title":"Clin Rheumatol"},{"key":"743_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","volume":"22","author":"M Jarlborg","year":"2020","unstructured":"Jarlborg M, Courvoisier DS, Lamacchia C, et al. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther. 2020;22:105. https:\/\/doi.org\/10.1186\/s13075-020-02190-3.","journal-title":"Arthritis Res Ther"},{"key":"743_CR12","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed 19 Apr 2021."},{"key":"743_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4.","journal-title":"Nat Rev Immunol"},{"key":"743_CR14","doi-asserted-by":"publisher","first-page":"155151","DOI":"10.1016\/j.cyto.2020.155151","volume":"133","author":"M Mahmudpour","year":"2020","unstructured":"Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133:155151.","journal-title":"Cytokine"},{"issue":"6","key":"743_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin A, Chapuis N, Dunsmore G, et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell. 2020;182(6):1401-1418.e18. https:\/\/doi.org\/10.1016\/j.cell.2020.08.002.","journal-title":"Cell"},{"key":"743_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1905526","author":"M Mahler","year":"2021","unstructured":"Mahler M, Meroni PL, Infantino M, Buhler KA, Fritzler MJ. Circulating calprotectin as a biomarker of COVID-19 severity. Expert Rev Clin Immunol. 2021. https:\/\/doi.org\/10.1080\/1744666X.2021.1905526.","journal-title":"Expert Rev Clin Immunol"},{"issue":"10","key":"743_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","volume":"5","author":"R Zampino","year":"2013","unstructured":"Zampino R, Marrone A, Restivo L, et al. Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol. 2013;5(10):528\u201340. https:\/\/doi.org\/10.4254\/wjh.v5.i10.528.","journal-title":"World J Hepatol"},{"issue":"1","key":"743_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2049936115585942","volume":"3","author":"P Cacoub","year":"2016","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Desbois AC, Saadoun D. Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis. 2016;3(1):3\u201314. https:\/\/doi.org\/10.1177\/2049936115585942.","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"743_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/RUQ.0000000000000369","volume":"34","author":"L Iliescu","year":"2018","unstructured":"Iliescu L, Mercan-Stanciu A, Ioanitescu ES, Toma L. Hepatitis C-associated B-cell non-Hodgkin lymphoma: a pictorial review. Ultrasound Q. 2018;34(3):156\u201366.","journal-title":"Ultrasound Q"},{"key":"743_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12882-020-1687-1","volume":"21","author":"EL Iliescu","year":"2020","unstructured":"Iliescu EL, Mercan-Stanciu A, Toma L. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. BMC Nephrol. 2020;21:21.","journal-title":"BMC Nephrol"},{"issue":"4","key":"743_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4183\/aeb.2018.533","volume":"14","author":"L Iliescu","year":"2018","unstructured":"Iliescu L, Mercan-Stanciu A, Toma L, Ioanitescu ES. A severe case of hyperglycemia in a kidney transplant recipient undergoing interferon-free therapy for chronic hepatitis C. Acta Endocrinol (Buchar). 2018;14(4):533\u20138.","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"1","key":"743_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.15403\/jgld.2014.1121.lil","volume":"24","author":"L Iliescu","year":"2015","unstructured":"Iliescu L, Herlea V, Toma L, Orban C. Association between chronic HCV hepatitis, membranoproliferative glomerulopathy and cutaneous sarcoidosis. J Gastrointest Liver Dis. 2015;24(1):8.","journal-title":"J Gastrointest Liver Dis"},{"issue":"3","key":"743_CR23","first-page":"3217","volume":"9","author":"YA Elnaggar","year":"2020","unstructured":"Elnaggar YA, Zidan HE, Abdelbaky EM, Wadea FM. Association of increased fecal calprotectin levels with hepatic encephalopathy and spontaneous peritonitis in Egyptian cirrhotic patients. J Gastroenterol Hepatol Res. 2020;9(3):3217\u201322.","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"12","key":"743_CR24","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s00432-020-03363-y","volume":"146","author":"AS Hanafy","year":"2020","unstructured":"Hanafy AS, Mohamed MS, Alnagar AA. Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites. J Cancer Res Clin Oncol. 2020;146(12):3207\u201314. https:\/\/doi.org\/10.1007\/s00432-020-03363-y.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"743_CR25","first-page":"115","volume":"2","author":"M El-Din","year":"2015","unstructured":"El-Din M, Salem H, Mansour MA, El saady Khayyal A, Mohsen M, Mansour K. Relation between Fecal Calprotectin concentration and severity of Hepatitis C (HCV) related chronic liver disease. Int J Adv Res Biol Sci. 2015;2(7):115\u201325.","journal-title":"Int J Adv Res Biol Sci"},{"issue":"3","key":"743_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, Pujari VB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121\u20136. https:\/\/doi.org\/10.4103\/aam.aam_56_18.","journal-title":"Ann Afr Med"},{"key":"743_CR27","first-page":"1723","volume":"150","author":"RP Negus","year":"1997","unstructured":"Negus RP, Stamp GW, Hadley J, Balkwill FR. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol. 1997;150:1723\u201334.","journal-title":"Am J Pathol"},{"issue":"16","key":"743_CR28","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","volume":"7","author":"M Dirchwolf","year":"2015","unstructured":"Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol. 2015;7(16):1974\u201381. https:\/\/doi.org\/10.4254\/wjh.v7.i16.1974.","journal-title":"World J Hepatol"},{"key":"743_CR29","unstructured":"Clinical management of COVID-19: living guidance, WHO REFERENCE NUMBER:\u00a0WHO\/2019-nCoV\/clinical\/2021.1. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-1. Accessed 3rd June 2021."},{"issue":"11","key":"743_CR30","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","volume":"13","author":"MA Chowdhury","year":"2020","unstructured":"Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: a review. J Infect Public Health. 2020;13(11):1619\u201329. https:\/\/doi.org\/10.1016\/j.jiph.2020.07.001.","journal-title":"J Infect Public Health"},{"issue":"1","key":"743_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2020.07.042","volume":"74","author":"S Blach","year":"2021","unstructured":"Blach S, Kondili LA, Aghemo A, et al. Impact of COVID-19 on global HCV elimination efforts. J Hepatol. 2021;74(1):31\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.042.","journal-title":"J Hepatol"},{"issue":"1","key":"743_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/19336950.2020.1837439","volume":"14","author":"H Alothaid","year":"2020","unstructured":"Alothaid H, Aldughaim M, El Bakkouri K, AlMashhadi S, Al-Qahtani AA. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment. Channels (Austin, TX). 2020;14(1):403\u201312. https:\/\/doi.org\/10.1080\/19336950.2020.1837439.","journal-title":"Channels (Austin, TX)"},{"issue":"5","key":"743_CR33","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC202009010","volume":"173","author":"DE Kaplan","year":"2020","unstructured":"Kaplan DE. Hepatitis C virus. Ann Intern Med. 2020;173(5):ITC33\u201348. https:\/\/doi.org\/10.7326\/AITC202009010.","journal-title":"Ann Intern Med"},{"issue":"5","key":"743_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11904-019-00466-1","volume":"16","author":"A Mohanty","year":"2019","unstructured":"Mohanty A, Salameh S, Butt AA. Impact of direct acting antiviral agent therapy upon extrahepatic manifestations of hepatitis C virus infection. Curr HIV\/AIDS Rep. 2019;16(5):389\u201394. https:\/\/doi.org\/10.1007\/s11904-019-00466-1.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"743_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196908","volume":"13","author":"DM Evon","year":"2018","unstructured":"Evon DM, Stewart PW, Amador J, et al. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: results from a large US multi-center observational study. PLoS ONE. 2018;13(8): e0196908. https:\/\/doi.org\/10.1371\/journal.pone.0196908.","journal-title":"PLoS ONE"},{"key":"743_CR36","doi-asserted-by":"publisher","first-page":"e20200714","DOI":"10.1590\/0037-8682-0714-2020","volume":"53","author":"F Silva","year":"2020","unstructured":"Silva F, Brito BB, Santos M, et al. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Med Trop. 2020;53:e20200714. https:\/\/doi.org\/10.1590\/0037-8682-0714-2020.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"7","key":"743_CR37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/lary.28692","volume":"130","author":"LA Vaira","year":"2020","unstructured":"Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130(7):1787. https:\/\/doi.org\/10.1002\/lary.28692.","journal-title":"Laryngoscope"},{"issue":"9","key":"743_CR38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/alr.22593","volume":"10","author":"LA Vaira","year":"2020","unstructured":"Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103\u20134. https:\/\/doi.org\/10.1002\/alr.22593.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1220\u20131230","key":"743_CR39","first-page":"1230.e1","volume":"141","author":"NG Sandler","year":"2011","unstructured":"Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. 2011;141(1220\u20131230):1230.e1-e3.","journal-title":"Gastroenterology"},{"key":"743_CR40","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","volume":"130","author":"G Leandro","year":"2006","unstructured":"Leandro G, Mangia A, Hui J, et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology. 2006;130:1636\u201342.","journal-title":"Gastroenterology"},{"key":"743_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/qjmed\/hci001","volume":"98","author":"H Knobler","year":"2005","unstructured":"Knobler H, Schattner A. TNF-\u03b1, chronic hepatitis C and diabetes: a novel triad. QJM. 2005;98:1\u20136.","journal-title":"QJM"},{"issue":"4","key":"743_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1185\/030079905X38141","volume":"21","author":"M Elsammak","year":"2005","unstructured":"Elsammak M, Refai W, Elsawaf A, Abdel-Fattah I, Abd Elatti E, Ghazal A. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients. Curr Med Res Opin. 2005;21(4):527\u201333. https:\/\/doi.org\/10.1185\/030079905X38141.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"743_CR43","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/diacare.27.11.2669","volume":"27","author":"A Lecube","year":"2004","unstructured":"Lecube A, Hern\u00e1ndez C, Genesc\u00e0 J, et al. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care. 2004;27(11):2669\u201375. https:\/\/doi.org\/10.2337\/diacare.27.11.2669.","journal-title":"Diabetes Care"},{"key":"743_CR44","doi-asserted-by":"publisher","first-page":"19744","DOI":"10.1038\/s41598-020-76871-z","volume":"10","author":"ML Chang","year":"2020","unstructured":"Chang ML, Hu JH, Yen CH, et al. Evolution of ferritin levels in hepatitis C patients treated with antivirals. Sci Rep. 2020;10:19744. https:\/\/doi.org\/10.1038\/s41598-020-76871-z.","journal-title":"Sci Rep"},{"issue":"7","key":"743_CR45","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.14309\/ajg.0000000000000691","volume":"115","author":"M Chunxiang","year":"2020","unstructured":"Chunxiang M, Yingzi C, Hu Z. COVID-19 and the digestive system. Am J Gastroenterol. 2020;115(7):1003\u20136. https:\/\/doi.org\/10.14309\/ajg.0000000000000691.","journal-title":"Am J Gastroenterol"},{"key":"743_CR46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/gutjnl-2020-320953","volume":"69","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kang Z, Gong H, et al. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69:1010\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2020-320953.","journal-title":"Gut"},{"issue":"1","key":"743_CR47","first-page":"147","volume":"49","author":"K Xu","year":"2020","unstructured":"Xu K, Cai H, Shen Y, et al. Management of corona virus disease-19 (COVID-19): The Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(1):147\u201357.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"743_CR48","doi-asserted-by":"publisher","first-page":"175346662093717","DOI":"10.1177\/1753466620937175","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175. https:\/\/doi.org\/10.1177\/1753466620937175.","journal-title":"Ther Adv Respir Dis"},{"key":"743_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134.","journal-title":"Lancet"},{"issue":"3","key":"743_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.dld.2020.10.021","volume":"53","author":"A Jena","year":"2021","unstructured":"Jena A, Kumar-MP Singh AK, Sharma V. Fecal calprotectin levels in COVID-19: lessons from a systematic review on its use in inflammatory bowel disease during the pandemic. Dig Liver Dis. 2021;53(3):295\u20137. https:\/\/doi.org\/10.1016\/j.dld.2020.10.021.","journal-title":"Dig Liver Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00743-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00743-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00743-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T12:16:23Z","timestamp":1652703383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00743-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["743"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00743-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-497871\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was waived by the Ethics Committee of Fundeni Clinical Institute given that this research study was conducted retrospectively from data obtained for clinical purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}